Biocon Ltd.
112Patents
78Active
112Granted
54Portfolio score
Filing activity: May 3, 1982 → Jun 4, 2021 · 29 expiring within 5 years
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7648962B2 | Natriuretic compounds, conjugates, and uses thereof | Human Necessities | 33 | Expired |
| US7662773B2 | Natriuretic compounds, conjugates, and uses thereof | Chemistry; Metallurgy | 27 | Active |
| US7425578B2 | Immunoregulatory compounds and derivatives and methods of treating diseases therewith | Emerging Cross-Sectional Technologies | 20 | Active |
| US6867306B2 | Process for the synthesis of atorvastatin form v and phenylboronates as intermediate compounds | Chemistry; Metallurgy | 20 | Expired |
| US8815247B2 | Targeted/immunomodulatory fusion proteins | Chemistry; Metallurgy | 19 | Active |
| US7605123B2 | Fatty acid formulations for oral delivery of proteins and peptides, and uses thereof | Human Necessities | 18 | Active |
| US5615627A | Method and apparatus for destruction of waste by thermal scission and chemical recombination | Mechanical Engineering; Lighting; Heating | 16 | Expired |
| US8759290B2 | Oral glucagon-like peptide conjugates for metabolic diseases | Human Necessities | 15 | Active |
| US8114632B2 | Method of producing biologically active polypeptide having insulinotropic activity | Chemistry; Metallurgy | 15 | Active |
| US7423014B2 | Insulin conjugates for treating diabetes mellitus | Human Necessities | 15 | Expired |
| US4521304A | Apparatus for biodegrading organic waste | Emerging Cross-Sectional Technologies | 11 | Expired |
| US8778659B2 | Method of reducing glycosylation of proteins, processes and proteins thereof | Chemistry; Metallurgy | 10 | Active |
| US7361772B2 | Process for the production of atorvastatin calcium | Chemistry; Metallurgy | 8 | Expired |
| US7470663B2 | Mixtures of insulin drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same | Human Necessities | 7 | Expired |
| US9670519B2 | Methods for reducing accumulation of lactate during culturing and method for producing polypeptide | Chemistry; Metallurgy | 7 | Active |
| US7875700B2 | Cation complexes of insulin compound conjugates, formulation and uses thereof | Human Necessities | 7 | Active |
| US7230120B2 | Amorphous HMG-CoA reductase inhibitors of desired particle size | Chemistry; Metallurgy | 7 | Expired |
| US7473366B2 | Process for the purification of macrolides | Chemistry; Metallurgy | 6 | Expired |
| US9217037B2 | Monoclonal antibody and a method thereof | Chemistry; Metallurgy | 6 | Active |
| US9670285B2 | Monoclonal antibody and a method thereof | Chemistry; Metallurgy | 6 | Active |
| US10000573B2 | Monoclonal antibody and a method thereof | Chemistry; Metallurgy | 5 | Active |
| US9758582B2 | Anti-CTLA4 antibody-TGF-βRII targeted/immunomodulatory fusion proteins | Chemistry; Metallurgy | 5 | Active |
| US7635675B2 | Micro-particle fatty acid salt solid dosage formulations for therapeutic agents | Human Necessities | 4 | Active |
| US9856502B2 | Methods for controlling fucosylation levels in proteins | Emerging Cross-Sectional Technologies | 4 | Active |
| US8133716B2 | Municipal solid waste treatment method and apparatus | Emerging Cross-Sectional Technologies | 4 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.